KOSDAQBatteries278280

Chunbo

₩28,750▲ 0.17%2026-11-18 close
Market Cap
₩352.3B
Turnover
₩500M
Volume
20K
Shares out.
12.3M
PER
—
PBR
0.9×
EPS
-₩7,331
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Losses persist; new plant ramp-up is the key test

Chunbo has recorded operating losses for four consecutive quarters through the third quarter of 2026, so the ramp-up of its new plants and shipments to North America remain the points to watch for a recovery.

  1. 1

    Operating profit turned positive in 2025 at KRW 3.71 billion, but the net loss attributable to controlling shareholders widened to KRW 57.8 billion.

  2. 2

    Third-quarter 2026 revenue rose 64.6% year on year to KRW 50.4 billion, while the operating loss of KRW 12.5 billion reversed a profit recorded in the same quarter of 2025.

  3. 3

    The net loss attributable to controlling shareholders over the last four quarters totals KRW 78.3 billion, with the fourth quarter of 2025 accounting for the largest share at KRW 50.7 billion.

  4. 4

    Revenue declined for three years starting in 2023 and has risen on a quarterly basis in 2026, but earnings improvement has not yet appeared.

  5. 5

    Supporting factors include the battery materials centered on P-electrolyte, electronic materials such as LCD etchant additives, and the target of cutting costs by about 50% at the new plants.

02

Business structure

Chunbo, founded in 2007 and listed on KOSDAQ in 2019, makes electrolytes and electrolyte additives for secondary batteries. In a 2023 report, the business mix was 68% secondary battery materials, 23.8% electronic materials, 4% other, 2.4% fine chemicals and 1.8% pharmaceutical materials.

According to a December 2025 report, a 17% drop in sales of P-electrolyte (LiPO2F2), which accounts for 61% of battery materials sales, was the direct cause of weakness in the third quarter of 2025.

In electronic materials, LCD etchant additives are described as holding the number one market share at home and abroad, and this segment supports profitability. Major customers named in a 2023 report include LG Energy Solution, Samsung SDI, Tesla and Panasonic.

By region, China's share of sales was estimated to have fallen from about 70% in 2025 to about 25%. Few companies mass-produce electrolyte additives, and a 2023 Korea Investment & Securities report described Chunbo as the only domestic firm able to supply additives at scale.

Overseas rivals include Mitsubishi Chemical, Chinese additive specialists and global chemical companies. The company is building a new F-electrolyte (LiFSI) plant with annual capacity of 2,500 tons and a new FEC additive plant in Gunsan.

A December 2025 report also said the company is pursuing materials for all-solid-state batteries and new additives.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩30.6B₩600M1.8%
2025Q4₩34.6B-₩2.5B−7.4%
2026Q1₩40.8B-₩3.4B−8.4%
2026Q2₩51B-₩3.8B−7.5%
2026Q3₩50.4B-₩12.5B−24.8%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩328.9B₩56.5B₩37.4B17.2%10.9%107.3%
2023₩182.7B-₩8B-₩41.8B−4.4%−14.1%166.4%
2024₩144.9B-₩22.8B-₩27.4B−15.7%−7.5%142.9%
2025₩133.8B₩3.7B-₩57.8B2.8%−13.6%81.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On a DART-filed annual basis, revenue fell from KRW 328.9 billion in 2022 to KRW 182.7 billion in 2023 (down 44.4% year on year), KRW 144.9 billion in 2024 (down 20.7%) and KRW 133.8 billion in 2025 (down 7.6%).

Revenue declined for three consecutive years from 2023 through 2025, with 2022 the largest year and 2025 the smallest in the 2022 to 2025 period. Operating profit of KRW 56.5 billion in 2022 (operating margin 17.2%) turned into an operating loss of KRW 8.04 billion in 2023 (margin -4.4%), a swing from profit to loss.

The operating loss widened to KRW 22.8 billion in 2024 (margin -15.7%), and operating profit returned to KRW 3.71 billion in 2025 (margin 2.8%). Because the 2025 profit came on a smaller revenue base, its margin remained well below the 17.2% of 2022.

Net income attributable to controlling shareholders went from KRW 37.4 billion in 2022 to a loss of KRW 41.8 billion in 2023, narrowed to a loss of KRW 27.4 billion in 2024 and widened again to a loss of KRW 57.8 billion in 2025.

Total net income including non-controlling interests moved from KRW 42.8 billion in 2022 to a loss of KRW 60 billion in 2025.

The controlling-shareholder loss widened in 2025 even though operating profit was positive, which points to a burden from non-operating items; the detail can be checked in the notes to the annual business report. The debt-to-equity ratio moved from 107.3% in 2022 to 166.4% in 2023, 142.9% in 2024 and 81.8% in 2025.

At the end of 2025, total liabilities were KRW 382.2 billion and total equity was KRW 467.4 billion, of which equity attributable to controlling shareholders was KRW 423.5 billion. Operating cash flow fell from KRW 65.6 billion in 2022 to KRW 57.2 billion in 2023, KRW 22.5 billion in 2024 and KRW 8.03 billion in 2025.

Quarterly revenue was KRW 30.6 billion in the third quarter of 2025, KRW 34.6 billion in the fourth quarter (up 12.9% from the prior quarter), KRW 40.8 billion in the first quarter of 2026 (up 17.9%), KRW 51 billion in the second quarter (up 25.1%) and KRW 50.4 billion in the third quarter of 2026 (down 1.1%).

Over the same period, operating profit of KRW 553 million in the third quarter of 2025 gave way to an operating loss of KRW 2.55 billion in the fourth quarter of 2025, KRW 3.41 billion in the first quarter of 2026, KRW 3.81 billion in the second quarter and KRW 12.5 billion in the third quarter of 2026.

Operating losses have run for four consecutive quarters, with the size of the loss increasing. In early 2026, Kiwoom Securities had forecast that the first quarter would turn to a loss on fixed-cost burdens from the Saemangeum plant ramp-up.

In the fourth quarter of 2025 the operating loss was KRW 2.55 billion, but the net loss attributable to controlling shareholders was much larger at KRW 50.7 billion, a gap that appears to come from non-operating items.

The net loss attributable to controlling shareholders over the last four quarters totals KRW 78.3 billion. In the third quarter of 2026 it was KRW 16.6 billion, a widening loss year on year, and the losses have continued for five consecutive quarters since the third quarter of 2025.

05

Industry analysis

The electrolyte and additive business is sensitive to battery raw material prices and to the supply prices set by Chinese producers. When operating profit fell sharply in the first quarter of 2023, the company attributed it to Chinese suppliers offering lithium salts and electrolyte additives below cost.

In early 2026, Kiwoom Securities noted that rising prices for LiPF6, a lithium-ion conductive salt not made in China, had raised expectations for electrolyte and additive makers.

The same report judged that a sustained rebound in the share price was still premature, given short-term overhang pressure and a delayed earnings recovery.

A third-quarter 2025 report said LiPO2F2 shipments to Chinese battery makers such as EVE Energy had risen, but that a worsening product mix from a larger China share would keep the average selling price roughly flat from the prior quarter.

The point is that a demand recovery does not translate directly into higher selling prices. A 2023 report said supply of lithium salts, solvents and additives was short across the electrolyte chain. A late 2025 report suggested the company could shift from an electrolyte specialist to a composite materials company.

It also said future growth depends on demand outside China. Few companies in Korea mass-produce electrolyte additives, a point repeated in the 2023 analysis.

The electronic materials business, including LCD etchant additives and process materials for semiconductors and OLEDs, has offset part of the weakness in battery materials.

06

Outlook

According to a December 2025 report, the new F-electrolyte (LiFSI) plant in Gunsan, with annual capacity of 2,500 tons, and the new FEC additive plant apply non-Chinese, lower-cost processes and target cost reductions of about 50% against the existing lines.

A report said the start of the new plants had been pushed back from the fourth quarter of 2025 to the first quarter of 2026. Kiwoom Securities said the key to better earnings is that shipments to North American OEM customers reach full scale and lift plant utilization.

The same report expected the group to reach its first quarterly profit in the third quarter of 2026. The third-quarter 2026 operating loss of KRW 12.5 billion did not match that expectation.

Three points are the next checks: whether operating losses continue in the fourth quarter of 2026 preliminary results, whether utilization at the Saemangeum and Gunsan plants rises, and whether sales outside China grow enough to offset the lower China share.

The 2026 annual business report must be filed by the end of March 2027, when full-year operating results and the debt structure will be confirmed in the DART filing.

The balance of KRW 467.4 billion in total equity and KRW 382.2 billion in total liabilities at the end of 2025 could change depending on new plant investment and the repayment plan for bonds.

07

Valuation

PER
—
PBR
0.9×
ROE
-19.7%
EPS
-₩7,331
BPS
₩36,119
Dividend per share
₩0

Because the company has posted net losses attributable to controlling shareholders over the last four quarters, its price-to-earnings ratio cannot be calculated. By contrast, the price-to-book ratio sits below 1x, so the share price is low relative to book value.

Of the KRW 467.4 billion in total equity at the end of 2025, KRW 423.5 billion is attributable to controlling shareholders, and this is the base for book-value comparisons. A share price below net asset value can reflect market judgments on the pace of earnings recovery and the burden of bond repayment.

Market views differ: one holds that the discount to book value will persist until earnings recover, while another holds that the book equity itself is the foundation for a recovery. The dividend yield remains low, so the earnings recovery rather than shareholder returns is the central point of evaluation.

Net income attributable to controlling shareholders was KRW 37.4 billion in 2022, so the current valuation can be compared with that earnings base to judge how much recovery is priced in.

The debt-to-equity ratio fell to 81.8% in 2025 from 2022, but total liabilities of KRW 382.2 billion at the end of 2025 remain large relative to total equity.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Electrolyte-centered battery sales and resilient electronic materials

According to a December 2025 report, P-electrolyte (LiPO2F2) accounts for 61% of battery materials sales. The same report said stable demand for electronic materials, including LCD etchant additives, supports profitability.

The argument for the bull case is that a portfolio spanning electrolytes, additives and electronic materials can partly cushion price swings in any single product line.

Quarterly revenue recovery in 2026

On a DART-filed basis, quarterly revenue rose from KRW 30.6 billion in the third quarter of 2025 to KRW 51 billion in the second quarter of 2026. Third-quarter 2026 revenue of KRW 50.4 billion was up 64.6% year on year. It edged down 1.1% from the prior quarter but remained far above the same quarter of 2025.

Cost-reduction target and the LiPF6 price factor

The new F-electrolyte (LiFSI) and FEC additive plants in Gunsan apply non-Chinese, lower-cost processes and target cost reductions of about 50% against existing lines. In early 2026 Kiwoom Securities noted that rising prices for non-Chinese LiPF6 had raised expectations for electrolyte and additive makers.

The bull case centers on whether those cost savings translate into margins that change the operating loss profile.

09

Bear factors

Four consecutive quarters of operating losses and a wider loss

Operating losses have continued from the fourth quarter of 2025 through the third quarter of 2026. The third-quarter 2026 operating loss of KRW 12.5 billion was much larger than the KRW 3.81 billion in the second quarter.

The net loss attributable to controlling shareholders over the last four quarters totals KRW 78.3 billion. The bear case starts from the fact that the fixed-cost burden of new plants that analysts pointed to is showing up in results.

Lower China share and selling-price pressure

In the third quarter of 2025, P-electrolyte sales fell 17% on lower selling prices. China's share of sales was estimated to have fallen from about 70% in 2025 to about 25%.

In the first quarter of 2023 the company said Chinese suppliers offering lithium salts and additives below cost had sharply reduced operating profit. Repeated price competition and product-mix shifts could slow the pace of margin recovery.

Bond obligations and liquidity pressure

A 2025 report raised concern that repaying KRW 200 billion in bonds would be difficult with current liquid assets. The same report cited cash and equivalents of KRW 4.3 billion on a standalone basis at the end of the third quarter of 2025.

Even with the debt ratio down to 81.8%, securing funds to cover total liabilities of KRW 382.2 billion at the end of 2025 remains a bear-case concern.

10

Risk factors

Delayed plant ramp-up

A report said the start of the Saemangeum plant had been delayed from the fourth quarter of 2025 to the first quarter of 2026. While utilization is low, fixed costs are booked as expenses, and that pattern has kept 2026 quarterly operating losses wide.

If shipments to North American OEM customers come later than expected, the timing of higher utilization could slip as well.

Balance sheet and bond repayment

Total liabilities at the end of 2025 were KRW 382.2 billion, a large amount against total equity of KRW 467.4 billion. Repayment of roughly KRW 200 billion in bonds and the possibility of conversion requests from financial investors have been cited as market concerns.

If repayment leads to new share issuance or cash outflows, it could affect the value attributable to controlling shareholders.

China exposure and price and raw material swings

China's share of sales was estimated to have fallen from about 70% in 2025 to about 25%, while an analysis noted that a larger China share worsens the product mix and lowers average selling prices. When selling prices fall, the operating margin recovery is limited even if revenue grows. The direction of raw material prices such as LiPF6 is another variable that affects margins.

11

What to watch next

  1. Late January to early February 2027 (typical timing)

    Preliminary fourth-quarter 2026 results. The next checks are whether operating losses continue and whether the net loss attributable to controlling shareholders widens again from non-operating items, as it did in the fourth quarter of 2025 (KRW 50.7 billion).

  2. End of March 2027 (statutory filing deadline)

    Filing of the 2026 annual business report. Full-year operating results, total liabilities and the bond structure will be confirmed in DART filings.

  3. Around May 15, 2027 (first-quarter report filing deadline)

    First-quarter 2027 results. The next check is whether higher utilization at the Saemangeum and Gunsan plants translates into better operating results.

12

Overall view

Chunbo's filed results show revenue falling for three consecutive years after peaking in 2022. Despite a return to operating profit in 2025, the net loss attributable to controlling shareholders widened to KRW 57.8 billion.

Quarterly revenue rose to KRW 51 billion in the second quarter of 2026, but operating losses have continued for four consecutive quarters since the fourth quarter of 2025, reaching KRW 12.5 billion in the third quarter of 2026.

Strengths include the electrolyte product line centered on P-electrolyte, electronic materials such as LCD etchant additives, and the cost-reduction target at the new plants.

Weaknesses include the lower China share and falling selling prices, fixed-cost burdens from delayed plant ramp-up, and total liabilities of KRW 382.2 billion at the end of 2025 along with bond repayment pressure.

The debt-to-equity ratio fell to 81.8% in 2025 from 107.3% in 2022, but operating cash flow declined from KRW 65.6 billion in 2022 to KRW 8.03 billion in 2025.

The 2026 annual business report will confirm full-year operating results and cash flow, and the fourth-quarter 2026 preliminary results will show first whether losses persist.

With both supporting and opposing factors in play, plant utilization, shipments to North America and the share of sales outside China are the three variables that will shape the path to recovery.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. hankyung.com
  2. m.etnews.com
  3. dealsite.co.kr
  4. lunccoin.com
  5. inews24.com
  6. etoday.co.kr
  7. etoday.co.kr
  8. siglab.kr
  9. newsis.com
  10. news.nate.com
  11. v.daum.net
  12. news1.kr
  13. dailyinvest.kr
  14. news.nate.com
  15. ftoday.co.kr
  16. judal.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis